After a single intravenous (IV) administration, single intramuscular (IM) administrations at three doses in successive increments along with repeated IM administrations, the elimination half-life (t 1/2 ) of prototype BPC157 was less than 30 min, and BPC157 showed linear pharmacokinetic characteristics in rats and beagle dogs at all doses
Is BPC-157 banned in competitive sports
Technical Specifications About This Peptide BPC-157 (Body Protection Compound-157), catalogued under internal code BPC-157, is a synthetic pentadecapeptide comprising 15 amino acids derived from a partial sequence of human gastric juice protein
Understand that: benefits are uncertain risks are unknown product quality varies We encourage patients to keep us informed so we can support your care safely
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocuta- neous fistulas in rats: role of the nitric oxide-system